PMC3927005_01
Transesophageal echocardiographic images. Arrows designate the inflow cannula of implantable LVAD (left ventricular assist device). (A) Midesophageal long axis view. (B) Basal short axis view.
kjae-66-67-g001.jpg
PMC3927005_01_kjae-66-67-g001.jpg
F1
TEE showed the correct placement of inflow cannula near the LV apex (Fig. 1) and no evidence of mitral regurgitation or right ventricular (RV) dysfunction. Twenty parts per million (PPM) of inhaled nitric oxide, 0.38 microg/kg/min of milrinone, and 2 microg/kg/min of isoproterenol were started to use before CPB weaning for preventing RV dysfunction after LVAD placement.